Clinical Trials on Influenza A Subtype H5N1 Infection in Hong Kong

Total 239 results

The University of Hong Kong
Queen Elizabeth Hospital, Hong Kong; Queen Mary Hospital, Hong Kong; Pamela Youde... and other collaborators

Completed

H-IVIG Treatment for Severe H1N1 2009

Novel 2009 Influenza A (H1N1) Infection

Hong Kong
Institute of Vaccines and Medical Biologicals,...
Department of Health and Human Services; Institut Pasteur; PATH; World Health Organization

Completed

Influenza A/H5N1 Vaccine Clinical Trial (IVACFLU-A/H5N1) - Phase 1

Influenza A Subtype H5N1 Infection

Vietnam
Sanwa BioTech Limited
Chinese University of Hong Kong; Prince of Wales Hospital, Shatin, Hong Kong

Not yet recruiting

Influenza A+B Test Kit Performance Study

Influenza Type B | Influenza Type A

Hong Kong
The University of Hong Kong

Unknown

Flufenamic Acid for Hospitalised Influenza Infection

Influenza A

Hong Kong
The University of Hong Kong

Withdrawn

Novel Assays for Detection of Influenza Virus

Influenza A Virus

Hong Kong
The University of Hong Kong

Completed

Convalescent Plasma Treatment in Severe 2009 H1N1 Infection

Influenza A

China
The University of Hong Kong

Completed

Direct and Indirect Benefits of Influenza Vaccination in Schools and Households

Acute Respiratory Infection | Influenza-like Illness | Influenza Virus Infection

Hong Kong
The University of Hong Kong

Completed

Intradermal Influenza Vaccine in the Young

Influenza Viral Infections

China
The University of Hong Kong

Suspended

Immunomodulatory Effect of Macrolides in Naturally Occurring Influenza Virus Infections in the Community

Influenza, Human

Hong Kong
Chinese University of Hong Kong
Food and Health Bureau, Hong Kong; Hospital Authority

Terminated

A Clinical Trial Comparing Oseltamivir With Placebo And Zanamivir With Control As First Line Treatment For Human Swine Influenza Infection

Influenza | Upper Respiratory Tract Infection

China, Hong Kong
The University of Hong Kong
Research Grants Council, Hong Kong; Research Fund for the Control of Infectious... and other collaborators

Completed

Direct and Indirect Benefits of Influenza Vaccine Versus Placebo in Healthy Children

Influenza Virus Infection

China
Chinese University of Hong Kong

Completed

Anti-inflammatory Effects of Macrolide Treatment in Influenza Lower Respiratory Tract Infections

Influenza | Lower Respiratory Tract Infection

Hong Kong
The University of Hong Kong
Food and Health Bureau, Hong Kong

Completed

Brief Influenza Vaccine Education to Pregnant Women

Pregnancy | Infectious Disease | Influenza

Hong Kong
The University of Hong Kong
Hospital Authority, Hong Kong

Completed

Dose Sparing Intradermal S-OIV H1N1 Influenza Vaccination Device

Influenza Infection

China
The University of Hong Kong

Completed

Treatment of Severe Influenza A Infection

Influenza, Human

Hong Kong
Chinese University of Hong Kong

Recruiting

Adjunctive Sirolimus and Oseltamivir Versus Oseltamivir Alone for Treatment of Influenza

Influenza

Hong Kong
Chinese University of Hong Kong

Recruiting

Intravenous N-acetylcysteine and Oseltamivir Versus Oseltamivir in Adults Hospitalized With Influenza and Pneumonia

Influenza

Hong Kong
The University of Hong Kong
National Institute of Allergy and Infectious Diseases (NIAID); University of...

Active, not recruiting

Dynamics of the Immune Responses to Repeat Influenza Vaccination Exposures (DRIVE)

Influenza, Human

Hong Kong
The University of Hong Kong

Recruiting

Intradermal Influenza Vaccine With Topical Imiquimod in Elderly and Chronic Illness Patients

Influenza

Hong Kong
The University of Hong Kong

Unknown

Improving Influenza Vaccination Rates in Nurses Through Text Message Reminders : a RCT

Influenza

China
Chinese University of Hong Kong
BioCryst Pharmaceuticals

Completed

Peramivir Treatment Response in Adults Hospitalized for Influenza-associated Lower Respiratory Tract Infections

Influenza

China
The University of Hong Kong
Hospital Authority, Hong Kong

Completed

2010/2011 Trivalent Influenza Vaccination

Influenza

China
The University of Hong Kong
Centers for Disease Control and Prevention; Hospital Authority, Hong Kong

Active, not recruiting

Immunogenicity of Twice-annual Influenza Vaccination in Older Adults in Hong Kong (RETAIN)

Influenza, Human

China
The University of Hong Kong

Unknown

Safety and Efficacy of Intradermal Trivalent Influenza Vaccination in Institutionalized Older Adults

Influenza, Human

China
Humanity and Health Research Centre
Beijing 302 Hospital; Nanfang Hospital of Southern Medical University

Completed

DAAs Treatment for Chronic HCV/HBV Co-infection Patients(DASCO) (DASCO)

Chronic Hepatitis C Infection | Hepatitis B Reactivation | HBV Coinfection

China
The University of Hong Kong

Completed

Intradermal Trivalent Influenza Vaccine With Imiquimod

Chronic Illness

Hong Kong
The University of Hong Kong
Centers for Disease Control and Prevention

Active, not recruiting

Immunogenicity of Alternative Annual Influenza Vaccination Strategies in Older Adults in Hong Kong (PIVOT)

Influenza, Human

China
Chinese University of Hong Kong
Hoffmann-La Roche

Completed

A Study on Higher-dose Oseltamivir Treatment's Impact on Viral Clearance and Clinical Recovery in Adults Hospitalized With Influenza

Respiratory Tract Infections | Influenza

Hong Kong
Centers for Disease Control and Prevention
The University of Hong Kong

Completed

A Randomised Controlled Trial of Face Masks and Hand Hygiene in Reducing Influenza Transmission in Households

Influenza

China
Chinese University of Hong Kong
The University of Hong Kong

Recruiting

Tropism and Pathogenesis of Influenza Virus and Coronavirus in Human Brain Explant Culture (COVID-19)

Coronavirus | Influenza Virus

Hong Kong
Ology Bioservices

Completed

Safety and Immunogenicity Study of Two Doses of an Inactivated H5N1 Influenza Vaccine (Whole Virion, Vero Cell Derived)

Influenza

Singapore, Hong Kong
The University of Hong Kong
Hospital Authority, Hong Kong

Completed

Quality of Life and Health Utility of Patients With CHB Infections

Chronic Hepatitis B Infection

Hong Kong
The University of Hong Kong

Completed

The Benefit and Harm of Fever Suppression by Antipyretics in Influenza

Influenza

China
The University of Hong Kong
Research Grant Council

Recruiting

Effects of Empagliflozin on Fibrosis and Cirrhosis in Chronic Hepatitis B

Cirrhosis | NAFLD | Chronic Hepatitis b | Fibrosis, Liver | Empagliflozin | SGLT2 Inhibitors

Hong Kong
The University of Hong Kong

Completed

Evaluation of Paternal, Maternal and Obstetric Factors Leading to the Hepatitis B Immunization Failure in Hong Kong

Hepatitis B Infection

China
The University of Hong Kong

Completed

ID HBV Vaccination With Imiquimod in OBI

Hepatitis B

Hong Kong
Shanghai Pulmonary Hospital, Shanghai, China
The University of Hong Kong

Not yet recruiting

Impact of Inactivated Trivalent Influenza Vaccine on NSCLC Patients Receiving PD-1 / PD-L1 Inhibitors

Non Small Cell Lung Cancer | Influenza Vaccine

China
The University of Hong Kong

Recruiting

Detecting Occult HBV Infection in Liver Donors Positive for Antibody to Hepatitis B Core Antigen (Anti-HBc) (OBI)

Liver Transplant; Complications | Occult Hepatitis B

Hong Kong
GlaxoSmithKline

Completed

Assess Consistency of Immunogenicity of GlaxoSmithKline Biologicals' Pandemic Influenza Vaccine (GSK1562902A) in Adults

Influenza | Influenza Vaccines

Taiwan, Hong Kong, Thailand, Singapore
The University of Hong Kong

Completed

Risk of Hepatitis B Reactivation in Patients With Prior HBV Exposure Undergoing Rituximab-containing Chemotherapy: A Prospective Study

Exposure to Hepatitis B Virus

Hong Kong
The University of Hong Kong

Completed

Risk of Hepatitis B Reactivation After Bone Marrow Transplantation With Prior Hepatitis B Virus (HBV) Exposure

Exposure to Hepatitis B Virus

Hong Kong
F-star Therapeutics, Inc.
PRA Health Sciences

Terminated

Evaluating the Safety and Efficacy of Inarigivir in Non-cirrhotic Treatment Naive Subjects Infected With Hepatitis B Virus

Hepatitis B | Hepatitis B, Chronic | HBV

Hong Kong
The University of Hong Kong

Completed

Off Treatment Durability in Chronic Hepatitis B With Good Immune Control

Chronic Hepatitis B

Hong Kong
The University of Hong Kong
Gilead Sciences

Completed

Tenofovir in Asian Chronic Hepatitis B Patients

Chronic Hepatitis B

Hong Kong
Chinese University of Hong Kong

Completed

Serum Hepatitis B Surface Antigen Levels to Guide the Stopping of Entecavir in HBeAg-negative Chronic Hepatitis B

Chronic Hepatitis B

Hong Kong
Suzhou Ribo Life Science Co. Ltd.

Completed

A Single and Repeated Dose Escalation of RBD1016 in Subjects With Chronic Hepatitis B Virus (HBV) Infection

Chronic Hepatitis b

China
Chinese University of Hong Kong
University of Malaya

Terminated

Risk of Hepatitis Flare in Patients With Previous Hepatitis B Virus Exposure Amongst Patients

Immunosuppression | Occult Hepatitis B | Biological Substance; Adverse Effect

Hong Kong
Humanity and Health Research Centre

Recruiting

Change of Renal Function and Bone Mineral Density in CHB Patients Switch From TDF to TAF vs. Maintaining TDF (SWITAF)

Chronic Hepatitis B

Hong Kong
Chinese University of Hong Kong

Completed

Seroepidemiology of Viral Hepatitis in Hong Kong

Viral Hepatitis

China
GlaxoSmithKline

Completed

Immunogenicity of GSK Biologicals' Pandemic Influenza Vaccine (GSK1562902A) at Different Boosting Vaccination Schedules

Influenza

Taiwan, Hong Kong, Thailand, Singapore

Clinical Trials on Influenza A Subtype H5N1 Infection in Hong Kong

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Estonia

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations